NO961423D0 - Oligopeptider avledet fra C-reaktive proteinfragmenter - Google Patents

Oligopeptider avledet fra C-reaktive proteinfragmenter

Info

Publication number
NO961423D0
NO961423D0 NO961423A NO961423A NO961423D0 NO 961423 D0 NO961423 D0 NO 961423D0 NO 961423 A NO961423 A NO 961423A NO 961423 A NO961423 A NO 961423A NO 961423 D0 NO961423 D0 NO 961423D0
Authority
NO
Norway
Prior art keywords
pct
reactive protein
protein fragments
oligopeptides derived
derived
Prior art date
Application number
NO961423A
Other languages
English (en)
Other versions
NO961423L (no
Inventor
Patrizia Caretto
Flavio Leoni
Fabrizio Marcucci
Gianni Gromo
Paolo Mascagni
Massimo Pinori
Silvana Cappelletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of NO961423D0 publication Critical patent/NO961423D0/no
Publication of NO961423L publication Critical patent/NO961423L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961423A 1993-10-12 1996-04-11 Oligopeptider avledet fra C-reaktive proteinfragmenter NO961423L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
PCT/EP1994/001574 WO1995010531A1 (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments

Publications (2)

Publication Number Publication Date
NO961423D0 true NO961423D0 (no) 1996-04-11
NO961423L NO961423L (no) 1996-06-10

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961423A NO961423L (no) 1993-10-12 1996-04-11 Oligopeptider avledet fra C-reaktive proteinfragmenter

Country Status (19)

Country Link
US (1) US6057295A (no)
EP (1) EP0723552B1 (no)
JP (1) JP3221881B2 (no)
KR (1) KR100363408B1 (no)
CN (1) CN1041524C (no)
AT (1) ATE226591T1 (no)
AU (1) AU684511B2 (no)
CA (1) CA2173939C (no)
DE (1) DE69431603T2 (no)
DK (1) DK0723552T3 (no)
ES (1) ES2185652T3 (no)
FI (1) FI961584A (no)
HU (1) HUT75538A (no)
IL (1) IL109761A0 (no)
IT (1) IT1271486B (no)
NO (1) NO961423L (no)
PT (1) PT723552E (no)
WO (1) WO1995010531A1 (no)
ZA (1) ZA943610B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (en) * 2002-10-09 2004-04-14 3 D Gene Pharma Pyrolidine derivatives useful in treatment of hepatitis C virus infection
WO2010033240A2 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
DK2526119T3 (en) 2010-01-19 2018-07-30 Harvard College Manipulated opsonin for pathogen detection and treatment
WO2013012924A2 (en) 2011-07-18 2013-01-24 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
US10551379B2 (en) 2013-03-15 2020-02-04 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
AU2014268603B2 (en) 2013-05-21 2018-03-22 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3912986B1 (en) 2013-12-18 2023-12-13 President and Fellows of Harvard College Crp capture/detection of bacteria
CN108289928A (zh) 2015-08-06 2018-07-17 哈佛大学校长及研究员协会 改进的微生物-结合分子和其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0253190B1 (en) * 1986-07-16 1992-12-30 ENIRICERCHE S.p.A. Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
ATE226591T1 (de) 2002-11-15
FI961584A0 (fi) 1996-04-11
ITMI932154A1 (it) 1995-04-12
DE69431603D1 (de) 2002-11-28
JPH09503200A (ja) 1997-03-31
KR100363408B1 (ko) 2003-02-11
DK0723552T3 (da) 2003-02-24
JP3221881B2 (ja) 2001-10-22
PT723552E (pt) 2003-02-28
EP0723552A1 (en) 1996-07-31
WO1995010531A1 (en) 1995-04-20
ES2185652T3 (es) 2003-05-01
CN1041524C (zh) 1999-01-06
CN1133048A (zh) 1996-10-09
HU9600934D0 (en) 1996-08-28
AU684511B2 (en) 1997-12-18
ZA943610B (en) 1995-01-25
CA2173939A1 (en) 1995-04-20
IT1271486B (it) 1997-05-28
AU6844194A (en) 1995-05-04
CA2173939C (en) 2002-08-27
ITMI932154A0 (it) 1993-10-12
DE69431603T2 (de) 2003-03-13
US6057295A (en) 2000-05-02
EP0723552B1 (en) 2002-10-23
NO961423L (no) 1996-06-10
IL109761A0 (en) 1994-08-26
FI961584A (fi) 1996-04-11
HUT75538A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
ATE257390T1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
SE8902532L (sv) Bestaemning av plasmaproteiner
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
NO982715L (no) Endotel celle-proliferasjonsinhibitor og fremgangsmate for anvendelse
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
IL145689A0 (en) Methods
NO20011537L (no) Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
EP1364657A4 (en) REMEDIES AGAINST TUMORS AFFECTING HEMATOPOIETIC BODIES
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
ATE316136T1 (de) Nierenpolycystose-gen
EA200001127A1 (ru) Бактериальные феромоны и их использование
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
EA199801032A1 (ru) Белки zona pellucida для контрацепции
ATE239499T1 (de) Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen
GB9723824D0 (en) Cytostatic agents